University of Illinois Chicago
Chicago, Illinois, 60612, United States
NCT Number: NCT05111392
The study examines interactions between fluid availability in the gut and fluid retention in the body. The relative rate of fluid uptake, the expansion of the plasma volume, and percent of fluid retained by the body will be measured in response to ingestion of beverages of different composition. Healthy, euhydrated adults will be studied. The results will help establish formulations of beverages that sustain if not promote acute euhydration.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Phase 1 / Phase 2
Chicago, Illinois, 60612, United States
Using a randomized order for beverage treatments at three separate trials, subjects will ingest 1 Liter of one of three beverages in 10 minutes: water, a beverage with 2.5% glucose with 45 mmol sodium/L, or a beverage with 1.7% glucose with 60 mmol sodium/L. Before and repeatedly for 2 h after ingestion of the beverage, blood samples will be drawn for assessments of D2O, Hb, Hct, osmolality, sodium, and glucose. The rate of appearance of D2O will be evaluated using the area under the curve, the slope of the appearance, and half time to plateau. Comparisons will be made between beverages for indices of the rate of appearance of D2O, the change in PV over time, and cumulative urine excreted. The cumulative urine produced will be used to calculate a modified BHI for the two glucose-electrolyte beverages and water for comparison with 1.0 (expected for no beverage effect). We hypothesize faster absorption (D2O appearance rate), and better overall hydration (expanded PV and higher modified BHI) will occur for beverages containing glucose and sodium compared to water. Further, we hypothesize that of the electrolyte beverages, the beverage with higher sodium content will promote greater overall hydration (less urine excreted) than the beverage with lower sodium.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ingestion of one (1) liter of beverage with observation for 2 h
Ingestion of one (1) liter of beverage with observation for 2 h
Ingestion of one (1) liter of beverage with observation for 2 h
Time frame: 2 hours
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
Time frame: 2 hours
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
Time frame: 2 hours
Measure the rate of fluid uptake by the gut using appearance of deuterium oxide, or D2O, in the blood after ingesting a fixed volume of placebo.
Time frame: 2 hours
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
Time frame: 2 hours
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
Time frame: 2 hours
Measure fluid retention using the difference between ingested volume and cumulative urine excretion as a percentage of the ingested volume.
Time frame: 2 hours
Increase in plasma volume (water content of the blood) following ingestion of beverage
Time frame: 2 hours
Increase in plasma volume (water content of the blood) following ingestion of beverage
Time frame: 2 hours
Increase in plasma volume (water content of the blood) following ingestion of beverage
University of Illinois at Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07669909
Adherence Interventions, Behavior
Sfax, Sfax Governorate, Tunisia
View Trial DetailsNCT05451446
Dehydration, Hydration
Columbia, South Carolina, United States
View Trial DetailsNCT01360333
Dehydration, Hydration
Linköping, Sweden
View Trial DetailsNCT07653620
Dehydration, Hydration
Bradenton, Florida, United States
View Trial Details